Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors
2021 · BMC Medicine · 201 citations
https://doi.org/10.1186/s12916-021-02006-4
P
Peiwen Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
1.2K
Citations
14
h-index
16
i10-index
Peiwen Ma is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research & Immunotherapy and Immune Responses. The author has an h-index of 14, co-authored 44 publications.
Papers by this author
worksCAR-macrophage: An extensive immune enhancer to fight cancer
2022 · EBioMedicine · 110 citations
https://doi.org/10.1016/j.ebiom.2022.103873
The state of the art of bispecific antibodies for treating human malignancies
2021 · EMBO Molecular Medicine · 75 citations
https://doi.org/10.15252/emmm.202114291
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials
2022 · Molecular Therapy — Oncolytics · 52 citations
https://doi.org/10.1016/j.omto.2022.02.019
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
2022 · Journal of Hematology & Oncology · 23 citations
https://doi.org/10.1186/s13045-022-01227-1
Targeting rare tumors: new focus for clinical research in China
2022 · EMBO Molecular Medicine · 9 citations
https://doi.org/10.15252/emmm.202216415
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat